Related references
Note: Only part of the references are listed.Time trends of mortality in patients with non-functioning pituitary adenoma: a Swedish nationwide study
Daniel S. Olsson et al.
PITUITARY (2017)
Health-related quality of life in patients treated for nonfunctioning pituitary adenomas during the years 2000-2010
Atte Karppinen et al.
CLINICAL ENDOCRINOLOGY (2016)
Mortality in patients with non-functioning pituitary adenoma is increased: systematic analysis of 546 cases with long follow-up
Georgia Ntali et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas
Marco Losa et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
ACTH and gonadotropin deficiencies predict mortality in patients treated for nonfunctioning pituitary adenoma: long-term follow-up of 519 patients in two large European centres
Michael W. O'Reilly et al.
CLINICAL ENDOCRINOLOGY (2016)
Treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists
Y. Greenman et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
Silent subtype 3 pituitary adenomas are not always silent and represent poorly differentiated monomorphous plurihormonal Pit-1 lineage adenomas
Ozgur Mete et al.
MODERN PATHOLOGY (2016)
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Surgical Techniques and Technologies for the Management of Patients With Nonfunctioning Pituitary Adenomas
John S. Kuo et al.
NEUROSURGERY (2016)
HIF-1α Inhibition Sensitized Pituitary Adenoma Cells to Temozolomide by Regulating Presenilin I Expression and Autophagy
Zhang Kun et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2016)
Effect of pasireotide on glucose- and growth hormone-related biomarkers in patients with inadequately controlled acromegaly
Herbert A. Schmid et al.
ENDOCRINE (2016)
Targeting the folate receptor: diagnostic and therapeutic approaches to personalize cancer treatments
J. A. Ledermann et al.
ANNALS OF ONCOLOGY (2015)
Truncated somatostatin receptor variant sst5TMD4 confers aggressive features (proliferation, invasion and reduced octreotide response) to somatotropinomas
Raul M. Luque et al.
CANCER LETTERS (2015)
Targeting PI3K/mTOR Signaling Displays Potent Antitumor Efficacy against Nonfunctioning Pituitary Adenomas
Misu Lee et al.
CLINICAL CANCER RESEARCH (2015)
Dopamine receptor subtype 2 expression profile in nonfunctioning pituitary adenomas and in vivo response to cabergoline therapy
Leonardo Vieira Neto et al.
CLINICAL ENDOCRINOLOGY (2015)
The Complementary Role of Transcription Factors in the Accurate Diagnosis of Clinically Nonfunctioning Pituitary Adenomas
Hiroshi Nishioka et al.
ENDOCRINE PATHOLOGY (2015)
Medical Treatment of Cushing Disease New Targets, New Hope
Maria Fleseriu
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2015)
Fractionated stereotactic radiotherapy for large and invasive non-functioning pituitary adenomas: long-term clinical outcomes and volumetric MRI assessment of tumor response
Giuseppe Minniti et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)
Excess Mortality in Women and Young Adults With Nonfunctioning Pituitary Adenoma: A Swedish Nationwide Study
Daniel S. Olsson et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Long-Term Outcome and MGMT as a Predictive Marker in 24 Patients With Atypical Pituitary Adenomas and Pituitary Carcinomas Given Treatment With Temozolomide
Daniel Bengtsson et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Octreotide-Mediated Tumor-Targeted Drug Delivery via a Cleavable Doxorubicin Peptide Conjugate
Marco Lelle et al.
MOLECULAR PHARMACEUTICS (2015)
Ovarian Hyperstimulation Caused by Gonadotroph Pituitary Adenoma - Review
Jowita Halupczok et al.
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2015)
SSTR3 is a putative target for the medical treatment of gonadotroph adenomas of the pituitary
Misu Lee et al.
ENDOCRINE-RELATED CANCER (2015)
Optimal management of non-functioning pituitary adenomas
Yona Greenman et al.
ENDOCRINE (2015)
Follow-up and long-term outcome of nonfunctioning pituitary adenoma operated by transsphenoidal surgery with intraoperative high-field magnetic resonance imaging
Sven Berkmann et al.
ACTA NEUROCHIRURGICA (2014)
The PI3K/AKT/mTOR pathway in the pathophysiology and treatment of pituitary adenomas
Eric Monsalves et al.
ENDOCRINE-RELATED CANCER (2014)
Peptide receptor radionuclide therapy in a patient with disabling non-functioning pituitary adenoma
Jan Komor et al.
PITUITARY (2014)
Peptide receptor radionuclide therapy for aggressive atypical pituitary adenoma/carcinoma: variable clinical response in preliminary evaluation
Jillian Maclean et al.
PITUITARY (2014)
Current treatment protocols can offer a normal or near-normal quality of life in the majority of patients with non-functioning pituitary adenomas
Cristina Capatina et al.
CLINICAL ENDOCRINOLOGY (2013)
Antiproliferative, Antiinvasive, and Proapoptotic Activity of Folate Receptor α-Targeted Liposomal Doxorubicin in Nonfunctional Pituitary Adenoma Cells
Xiaohai Liu et al.
ENDOCRINOLOGY (2013)
Somatostatin receptors: From signaling to clinical practice
Marily Theodoropoulou et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2013)
Pyrimethamine sensitizes pituitary adenomas cells to temozolomide through cathepsin B-dependent and caspase-dependent apoptotic pathways
Congxin Dai et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
DNA Mismatch Repair Protein (MSH6) Correlated With the Responses of Atypical Pituitary Adenomas and Pituitary Carcinomas to Temozolomide: The National Cooperative Study by the Japan Society for Hypothalamic and Pituitary Tumors
Toshio Hirohata et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Gamma Knife radiosurgery for the management of nonfunctioning pituitary adenomas: a multicenter study
Jason P. Sheehan et al.
JOURNAL OF NEUROSURGERY (2013)
Value of endoscopy for maximizing tumor removal in endonasal transsphenoidal pituitary adenoma surgery Clinical article
Nancy McLaughlin et al.
JOURNAL OF NEUROSURGERY (2013)
Short-term treatment with cabergoline can lead to tumor shrinkage in patients with nonfunctioning pituitary adenomas
Erica C. Garcia et al.
PITUITARY (2013)
Gonadotroph Adenoma with Secondary Hypersecretion of Testosterone
Roukoz Chamoun et al.
WORLD NEUROSURGERY (2013)
Subclinical hyperfunctioning pituitary adenomas: The silent tumors
Odelia Cooper et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Peptide receptor radionuclide therapy (PRRT) for GEP-NETs
Hendrik Bergsma et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2012)
Pituitary carcinomas and aggressive pituitary tumours: merits and pitfalls of temozolomide treatment
Gerald Raverot et al.
CLINICAL ENDOCRINOLOGY (2012)
A pituitary adenoma secreting follicle-stimulating hormone with ovarian hyperstimulation: treatment using a gonadotropin-releasing hormone antagonist
Heraldo Mendes Garmes et al.
FERTILITY AND STERILITY (2012)
Glucocorticoid Replacement and Mortality in Patients with Nonfunctioning Pituitary Adenoma
Thomas Zueger et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Natural History of Postoperative Nonfunctioning Pituitary Adenomas: A Systematic Review and Meta-Analysis
Yong Chen et al.
NEUROENDOCRINOLOGY (2012)
Expression of dopamine 2 receptor subtype mRNA in clinically nonfunctioning pituitary adenomas
Zhipeng Su et al.
NEUROLOGICAL SCIENCES (2012)
Differential Expression of Folate Receptor Alpha in Pituitary Adenomas and Its Relationship to Tumor Behavior
Xiaohai Liu et al.
NEUROSURGERY (2012)
New targeted therapies in pituitary carcinoma resistant to temozolomide
Emmanuel Jouanneau et al.
PITUITARY (2012)
Treatment with octreotide LAR in clinically non-functioning pituitary adenoma: results from a case-control study
Alessandra Fusco et al.
PITUITARY (2012)
PI3K/Akt/mTOR and Raf/MEK/ERK signaling pathways perturbations in non-functioning pituitary adenomas
Hadara Rubinfeld et al.
ENDOCRINE (2012)
Aggressive pituitary tumours: the role of temozolomide and the assessment of MGMT status
Ann I. McCormack et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2011)
Can we ever stop imaging in surgically treated and radiotherapy-naive patients with non-functioning pituitary adenoma?
Raghava Reddy et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
Evidence of improved surgical outcome following endoscopy for nonfunctioning pituitary adenoma removal Personal experience and review of the literature
Mahmoud Messerer et al.
NEUROSURGICAL FOCUS (2011)
Somatostatin Receptor-Targeted Anti-Cancer Therapy
Li-Chun Sun et al.
CURRENT DRUG DELIVERY (2011)
The Somatostatin Analogue Octreotide Confers Sensitivity to Rapamycin Treatment on Pituitary Tumor Cells
Vesna Cerovac et al.
CANCER RESEARCH (2010)
Factors predicting relapse of nonfunctioning pituitary macroadenomas after neurosurgery: a study of 142 patients
Sophie Brochier et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
Effect of Everolimus on Cell Viability in Nonfunctioning Pituitary Adenomas
Maria Chiara Zatelli et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Temozolomide Treatment in Aggressive Pituitary Tumors and Pituitary Carcinomas: A French Multicenter Experience
Gerald Raverot et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
In Vivo Assay of Folate Receptors in Nonfunctional Pituitary Adenomas with 99mTc-Folate SPECT/CT
James R. Galt et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Testicular enlargement in a patient with a FSH-secreting pituitary adenoma
Per Dahlqvist et al.
ENDOCRINE (2010)
Non-functioning pituitary adenomas
Yona Greenman et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
The natural history of surgically treated but radiotherapy-naive nonfunctioning pituitary adenomas
Eoin P. O'Sullivan et al.
CLINICAL ENDOCRINOLOGY (2009)
Silent subtype 3 pituitary adenoma: a clinicopathologic analysis of the Mayo Clinic experience
D. Erickson et al.
CLINICAL ENDOCRINOLOGY (2009)
Differential Expression of Somatostatin and Dopamine Receptor Subtype Genes in Adrenocorticotropin (ACTH)-secreting Pituitary Tumors and Silent Corticotroph Adenomas
Toru Tateno et al.
ENDOCRINE JOURNAL (2009)
Activation of RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pituitary adenomas and their effects on downstream effectors
D. Dworakowska et al.
ENDOCRINE-RELATED CANCER (2009)
Predicting Recurrence of Nonfunctioning Pituitary Adenomas
Tae-Woong Noh et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Expression Analysis of Dopamine Receptor Subtypes in Normal Human Pituitaries, Nonfunctioning Pituitary Adenomas and Somatotropinomas, and the Association between Dopamine and Somatostatin Receptors with Clinical Response to Octreotide-LAR in Acromegaly
Leonardo Vieira Neto et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Radiotherapy of nonfunctioning and gonadotroph adenomas
Andrew A. Kanner et al.
PITUITARY (2009)
Disease-specific impairments in quality of life during long-term follow-up of patients with different pituitary adenomas
Agatha A. van der Klaauw et al.
CLINICAL ENDOCRINOLOGY (2008)
Efficacy of a dopamine-somatostatin chimeric molecule, BIM-23A760, in the control of cell growth from primary cultures of human non-functioning pituitary adenomas: a multi-center study
Tullio Florio et al.
ENDOCRINE-RELATED CANCER (2008)
Medical therapy for clinically non-functioning pituitary adenomas
Annamaria Colao et al.
ENDOCRINE-RELATED CANCER (2008)
Cabergoline and the risk of valvular lesions in endocrine disease
Patrizio Lancellotti et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Role of Ki-67 proliferation index and p53 expression in predicting progression of pituitary adenomas
Roger Gejman et al.
HUMAN PATHOLOGY (2008)
Early results of surgery in patients with nonfunctioning pituitary adenoma and analysis of the risk of tumor recurrence
Marco Losa et al.
JOURNAL OF NEUROSURGERY (2008)
Radiotherapy for nonfunctioning pituitary adenomas: from conventional to modern stereotactic radiation techniques
Giuseppe Minniti et al.
NEUROSURGICAL REVIEW (2007)
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion
Maria Chiara Zatelli et al.
ENDOCRINE-RELATED CANCER (2007)
Pathohistological classification of pituitary tumors:: 10 years of experience with the German Pituitary Tumor Registry
Wolfgang Saeger et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)
Valvular heart disease and the use of dopamine agonists for Parkinson's disease
Renzo Zanettini et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Quantitative analysis of somatostatin receptor subtype (SSTR1-5) gene expression levels in somatotropinomas and non-functioning pituitary adenomas
Giselle F. Taboada et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)
Quality of life is decreased after treatment for nonfunctioning pituitary macroadenoma
O. M. Dekkers et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Hypopituitarism and mortality in pituitary adenoma
J. Lindholm et al.
CLINICAL ENDOCRINOLOGY (2006)
Observation alone after transsphenoidal surgery for nonfunctioning pituitary macroadenoma
OM Dekkers et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
The 2004 World Health Organization classification of pituitary tumors: What is new?
M Al-Shraim et al.
ACTA NEUROPATHOLOGICA (2006)
Postoperative treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists decreases tumour remnant growth
Y Greenman et al.
CLINICAL ENDOCRINOLOGY (2005)
Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: Update after an additional 10 years
G Minniti et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Dopamine receptor expression and function in clinically nonfunctioning pituitary tumors: Comparison with the effectiveness of cabergoline treatment
R Pivonello et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Impact of primary surgery on pituitary function in patients with non-functioning pituitary adenomas - a study on 721 patients
P Nomikos et al.
ACTA NEUROCHIRURGICA (2004)
Evidence for differential effects of selective somatostatin receptor subtype agonists on α-subunit and chromogranin A secretion and on cell viability in human nonfunctioning pituitary adenomas in vitro
MC Zatelli et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Expression of Ki-67 antigen in nonfunctioning pituitary adenomas:: correlation with growth velocity and invasiveness
J Honegger et al.
JOURNAL OF NEUROSURGERY (2003)
Postoperative surveillance of clinically nonfunctioning pituitary macroadenomas: markers of tumour quiescence and regrowth
Y Greenman et al.
CLINICAL ENDOCRINOLOGY (2003)
Non-functioning pituitary adenomas with positive immunoreactivity for ACTH behave more aggressively than ACTH immunonegative tumours but do not recur more frequently
KJ Bradley et al.
CLINICAL ENDOCRINOLOGY (2003)
Risk factors for cerebrovascular deaths in patients operated and irradiated for pituitary tumors
EM Erfurth et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Dopamine D2 receptor gene expression in human adenohypophysial adenomas
L Stefaneanu et al.
ENDOCRINE (2001)
ACTH silent adenoma shrinking under cabergoline
P Petrossians et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2001)
In vivo secretory potential and the effect of combination therapy with octreotide and cabergoline in patients with clinically non-functioning pituitary adenomas
M Andersen et al.
CLINICAL ENDOCRINOLOGY (2001)
Receptors for dopamine and somatostatin: Formation of hetero-oligomers with enhanced functional activity
M Rocheville et al.
SCIENCE (2000)
Share Paper
